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capacity to mobilize CD11b to the same extent as cells fromImpaired monocyte CD11b expression in interstitial inflam-
healthy individuals at the inflammatory spot, but more intensemation in hemodialysis patients.
stimuli are required for such actions, probably because of aBackground. It is not known to what extent intravascular
transient refractoriness.phenotypic alterations in adhesion molecule expression in-
duced by hemodialysis influence the recruitment of monocytes
and their ability to up-regulate CD11b at the local site of
inflammation in the interstitium. Using a skin suction chamber The migration of leukocytes from the peripheral circu-technique, we addressed these issues in eight hemodialysis pa-
lation into interstitial spaces involves sequential interac-tients and in eight healthy subjects.
tions between activation-dependent molecules on theMethods. Two skin blisters were raised on the forearm of
each individual and blister exudate collected. The blisters were endothelium and leukocytes [1]. The initial recognition
then stimulated with autologous serum (active blister, intense and adhesion of the circulating leukocyte to vascular
inflammation) or buffer (control blister, intermediate inflam- endothelium at the site of inflammation are mediated bymation), respectively. Thereafter the patients were treated with
selectins. The second phase is mediated through integrinCuprophan hemodialysis for four hours. After 10 hours, the
molecules and involves activation of the leukocyte re-exudate was aspirated from each chamber in all subjects. Mono-
cyte count and expression of CD11b were analyzed in serum sulting in firm adhesion to the endothelium. The adher-
and blister fluid by flow cytometry. Then, monocytes from ent leukocytes then diapedese between endothelial cells
healthy blood donors were incubated in blister fluid from pa- and migrate through extravascular tissue along gradientstients and healthy subjects in order to determine the local
of chemoattractants diffusing from the inflammatory sitechemotactic activity in terms of CD11b up-regulation. Mono-
[2]. When the specific leukocyte has reached the point ofcyte chemotactic protein-1 (MCP-1), a marker of systemic
monocyte chemotactic activity, was also analyzed in serum at highest chemokine concentration, it arrests and secretes
0 and 10 hours in all individuals. cytokines and additional chemokines, resulting in further
Results. The number of monocytes at the site of inflamma- leukocyte accumulation. Neutrophils mediate an earlytion in the interstitium in hemodialysis patients correlated with
response to infection or tissue injury, whereas monocytesthe expression of CD11b on transmigrated cells (r 5 0.78, P ,
and lymphocytes typically are recruited in the later stages0.001). Monocytes collected in the active blister fluid of dialysis
patients expressed equal levels of CD11b as cells collected of the inflammatory response. It has been proposed that
from healthy subjects. By contrast, monocytes collected from several chemokines are involved in leukocyte recruit-
the control blisters of patients expressed lower levels of CD11b ment but also that certain chemokines, for example, mono-than cells from healthy subjects (P , 0.01), despite equal inter-
cyte chemotactic protein-1 (MCP-1) and interleukin-8stitial biological activity of CD11b-mobilizing factors in blister
(IL-8), may show restricted tissue expression and as afluid from patients and healthy subjects and the fact that pa-
tients had higher systemic chemotactic activity in terms of result are involved in organ-specific recruitment [1].
MCP-1 concentration in serum (P , 0.001). MCP-1 is a monocyte specific chemoattractant, and IL-8
Conclusion. Monocytes from hemodialysis patients have the acts as a neutrophil chemotaxin [2, 3]. Little is known
about the factors that control the type of chemokine
generated and what eventually terminates chemokineKey words: CD11b/CD18, adhesion molecules, monocyte chemoat-
tractant protein-1, skin suction chamber, transmigration. and cytokine production, which down-regulates the in-
flammatory response.Received for publication May 14, 1999
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bound leukocytosis [4]. This unphysiological activation of by a continuous intravenous infusion until one hour be-
fore termination of treatment.monocytes and neutrophils, resulting in rapid alterations
in adhesion molecule phenotypes, occurs in the extra- Blood samples were collected prior to dialysis and 10
hours after start of dialysis in ethylenediaminetetraaceticcorporeal circuit far away from the respective ligand on
the endothelial cell lining [5–7]. These phenotypic changes acid (EDTA) tubes, and kept on ice to prevent further
complement activation and receptor modulation. Bloodresult in defective adhesion of inflammatory cells to hu-
man endothelial cells [5, 7]. It is less well known to which from healthy subjects was collected at the corresponding
time points.extent these alterations in adhesion molecule expression
and cell count influence the capacity of monocytes and
Skin suction chambersneutrophils to be recruited into inflammatory sites.
In an attempt to address this issue, using a skin suction The monocyte response to cutaneous inflammation
was assessed by the skin suction chamber technique inchamber technique, we examined the in vivo ability of
monocytes to accumulate at induced inflammatory foci both patients and healthy subjects. Two skin blisters were
raised on the volar surface of one of the forearms (inin patients on hemodialysis.
hemodialysis patients the blood access-free forearm was
chosen; Fig. 1). After disinfection, the suction chamber
METHODS
was placed on the shaved, cleaned skin and secured on
Cell count and expression of adhesion molecule the arm. A constant vacuum (300 mm Hg) was applied
CD11b/CD18 were measured at 0 hours and after 10 by continuous gentle suction (Electronic Diversities,
hours on monocytes in the peripheral circulation and in Finksburg, MD, USA). Blister formation was promoted
skin blister fluid collected from hemodialysis patients on by heating (398C) until the blisters were sufficiently de-
the day of dialysis and from healthy subjects. veloped. Two 9 mm diameter blisters were formed in
two to three hours. The vacuum was then released, and
Study population
the suction chamber was removed. The blisters were
Eight hemodialysis patients (mean age 49 6 7 years, covered overnight with a plastic eye chamber (Augen-
range 35 to 67 years) undergoing maintenance hemodial- verband S; Lohmann GmbH, Munich, Germany). The
ysis with polysulfone dialyzers (F6 HPS and F7 HPS; next morning, 12 to 14 hours after the formation of blisters,
Fresenius AG, Bad Homburg, Germany) three times a the roof of the blisters was carefully removed after the
week participated in the study. All patients had been on blister fluid had been aspirated, pooled, and saved for
hemodialysis for more than six months. The dialyses in further analysis. This pool of exudate was designated
the study were part of the routine dialysis program. All 0 hours and, in the group of patients, represented the
patients suffering from infectious diseases, diabetes melli- conditions in the uremic state. To protect the intact skin
tus, chronic lung disease, or inflammatory diseases, as from irritation, a transparent sterile adhesive plastic film
well as patients receiving antibiotics, corticosteroids, or (Tegaderm; 3 M Pharmaceuticals, Loughborough, UK)
nonsteroidal anti-inflammatory agents were excluded. with a 10 mm diameter hole was applied around the ex-
Informed consent was obtained, and the study was ap- posed blister floor. Skin bond cement (Smith & Nephew
proved by the Ethics Committee of the Karolinska Hos- United, Inc., Largo, FL, USA) was then applied around
pital. Eight healthy subjects (mean age 35 6 2 years, the bottom edge of sterilized open-bottom plastic skin
range 24 to 52 years) without any medication were also chambers (volume 1 mL), which were placed over the
examined. unroofed blisters and secured. In the proximal chamber,
designated the active chamber, 1 mL of heparinized au-
Hemodialysis tologous serum was added (6 mL heparin added to 1 mL
All patients were switched to dialysis with Cuprophan serum). In the distal chamber, designated the control
hollow fiber dialyzers with a membrane area of 1.8 m2 chamber, 1 mL phosphate-buffered saline (PBS) and 6 mL
(Gambro Dialysatoren GmbH & Co., Hechingin, Ger- heparin were inserted. The administration of serum and
many) for four weeks before entering the study. Our buffer in the respective chambers was done in order to
hypothesis was that a more profound disturbance in ad- induce a difference in intensity of inflammation in the
hesion molecule expression, which occurs during Cupro- blisters: an intense inflammation in the chamber with
phan hemodialysis [6–8], would influence cell recruit- serum and an intermediate in that containing buffer. The
ment and expression of CD11b/CD18 at the local site autologous serum was collected the day before, centri-
of inflammation in the interstitium. Dialyzers were not fuged for 15 minutes at 48C, and immediately frozen at
reused. On the day of investigation, hemodialysis was 2708C. During the first four hours of incubation, Cupro-
performed for four hours with the Cuprophan dialyzer phan hemodialysis treatment was given to the patients.
and a blood flow of 300 mL/min. Heparin doses were After 10 hours of incubation, the fluid was aspirated
from each chamber and placed on ice (Fig. 1). The blisterindividualized and given as an initial bolus dose followed
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Fig. 1. Formation of blisters. (A) A suction chamber was placed and secured on one of the forearms, and a constant vacuum was applied. (B)
Two 9 mm blisters were formed in two to three hours. (C) The next morning, 12 to 14 hours after blister formation, blister fluid was aspirated.
(D) The roof of the blisters was carefully removed, and a sterilized open-bottom plastic skin chamber was placed over the unroofed blisters and
was secured. Thereafter, buffer or serum was added, as described in the Methods section.
fluid was centrifuged at 300 3 g for five minutes at 48C, Number of monocytes and analysis of CD11b/CD18
expression on cells in skin blister exudate and in theand the pellets were resuspended in PBS-EDTA and used
peripheral circulationfor flow cytometric analysis of monocytes. The rationale
for choosing 10 hours of incubation was based on a previ- In the blister exudate (one pooled sample aspirated
ous study in which we showed that phenotypic alterations from overnight intact blisters and two samples drawn
after 10 h from the active and control chambers, respec-in adhesion molecule expression on monocytes persist
tively), monocytes were counted using a flow cytometerup to 10 hours after Cuprophan hemodialysis [8].
(Epics Elite; Coulter Inc., Hialeah, FL, USA). This in-
strument gives the actual number of cells and the meanPreparation of peripheral leukocytes
fluorescence intensity (MFI), which represents the den-Ethylenediaminetetraacetic acid blood was hemolyzed
sity of the antigens of the cell population within a chosenin 100 mL portions by dilution in 2 mL 48C isotonic
field. CD11b/CD18 expression on monocytes was ana-
NH4Cl-EDTA “lyzing solution.” After five minutes of lyzed by adding 5 mL of phycoerythrin-conjugated mono-
incubation at 48C, the cells were centrifuged at 300 3 g clonal anti-CD11b (Dako AS, Glostrup, Denmark). An
for five minutes at 48C. The leukocytes were washed once appropriate concentration of an isotype-matched control
and resuspended in 100 mL cold 0.15 mol/L phosphate antibody was used to define the cut-off for positive fluo-
buffered saline (PBS) supplemented with 0.1 mmol/L rescence, which was the 99th percentile of the distribu-
EDTA and 0.2% Na-azide (PBS-EDTA) before immuno- tion of the cells labeled with the control antibody, PE-
conjugated IgG2a. Cell count and CD11b expression onstaining.
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monocytes were also analyzed in peripheral blood in
samples obtained at both time points.
In vitro mobilization of CD11b on monocytes from
healthy blood donors following incubation in blister
fluid from patients and healthy subjects
Monocyte preparations from healthy blood donors
were incubated in vitro in 100 mL cell-free skin blister
fluid obtained from 0 and 10 hours of active blister (stim-
ulated with autologous serum, intense inflammation) and
control blister (stimulated with PBS buffer, intermediate
inflammation). Preparations were diluted 1/2 in 1640
RPMI medium, supplemented with 0.01 mol/L HEPES
and 10% heat-inactivated fetal calf serum (RPMI-
HEPES; GIBCO Ltd., Paisley, Renfrewshire, UK) and
were incubated at 378C for 15 minutes. Monocytes acti-
vated in the presence of 5 3 1027 mol/L formyl-methio-
nyl-leucyl-phenylalanine (fMLP; Sigma Chemical Co.,
Dorsett, UK) for 15 minutes at 378C, served as a positive
control, and monocytes incubated in RPMI-HEPES
alone for 15 minutes at 378C and 48C, respectively, served
as negative controls. After incubation, the cell suspen-
sions were washed once in PBS-EDTA (300 3 g for 5 Fig. 2. Number of transmigrating monocytes into skin blisters of (A)
hemodialysis patients and (B) healthy subjects. This shows the 10th,min, 48C) and resuspended in 100 mL PBS-EDTA and
25th, 50th (median), 75th, and 90th percentiles of a variable. P , 0.001
kept at 48C until immunostaining and flow cytometric in patients (A) and P , 0.01 in healthy subjects (B) for control blisters
vs. active blisters.analysis (discussed previously in this article).
Analyses of MCP-1
Monocyte chemotactic protein-1 levels in serum were in Figure 2. The number of monocytes in the active
measured with a commercially available immunoassay chamber (intense inflammation) at 10 hours was signifi-
(the Quantikine Human MCP-1 Immunoassay; R&D Sys- cantly higher as compared with in the control chamber
tems, Inc., Minneapolis, MN, USA). The assay was done (intermediate inflammation) in both patients and healthy
according to the manufacturer’s instructions, and the subjects (Fig. 2). There was no significant difference be-
minimum detectable concentration of MCP-1 was 10 ng/L. tween the number of monocytes in skin blister fluid col-
lected from patients as compared with healthy subjects
Statistical analysis (Fig. 2).
Results are expressed as mean 6 SEM. The figures
Expression of CD11b/CD18 on monocytes in theare presented as boxplots showing the 10th, 25th, 50th
peripheral circulation(median), 75th, and 90th percentiles of a variable. Statis-
The expression of CD11b/CD18 on monocytes in thetical comparisons were made using analysis of variance
peripheral circulation was similar in patients and healthy(ANOVA), Mann Whitney U-test, and the Wilcoxon
subjects at both 0 and 10 hours. After 10 hours, 6 hourssigned-rank test for paired and unpaired observations.
after termination of Cuprophan hemodialysis, the ex-
pression of CD11b on the population of monocytes pres-
ent in the peripheral circulation was higher as comparedRESULTS
with before dialysis (P , 0.05; Fig. 3).
Number of transmigrating monocytes into skin
blister exudate Expression of CD11b/CD18 on transmigrating
monocytes in skin blister exudateThe number of monocytes collected in skin blister
exudate from dialysis patients in the uremic state (before The expression of CD11b/CD18 on transmigrating
dialysis) and healthy subjects at 0 hours and in the control monocytes was significantly higher in the skin blister
chamber (stimulated with buffer) and active chamber fluid at different time points as compared with in the
peripheral circulation at the corresponding time points(stimulated with human serum) at 10 hours is presented
Thyle´n et al: Monocyte CD11b expression and inflammation 2103
Fig. 3. Expression of CD11b/CD18 on monocytes in the peripheral
circulation of hemodialysis patients and healthy subjects. This shows
the 10th, 25th, 50th (median), 75th, and 90th percentiles of a variable.
P , 0.05 in patients for time 0 vs. time 10 hours.
(P , 0.001 for all of the comparisons; Figs. 3 and 4). The
expression of CD11b/CD18 on transmigrating mono-
cytes from patients on hemodialysis was significantly
higher in the active chamber (containing autologous se-
rum, intense inflammation) as compared with in the con-
trol chamber (containing buffer, intermediate inflamma-
tion) at 10 hours (P , 0.01; Fig. 4). There was, however,
no significant difference in the expression of CD11b/
CD18 on transmigrating monocytes collected from the
corresponding skin blisters of healthy subjects (Fig. 4).
The expression of CD11b/CD18 on transmigrating mono-
cytes was significantly higher in the control chamber of
healthy subjects as compared with in the corresponding
chamber of hemodialysis patients (P , 0.01; Fig. 4).
The number of monocytes at the site of inflammation
in the interstitium in hemodialysis patients (pooled data Fig. 4. Expression of CD11b/CD18 on transmigrating monocytes in
skin blisters of hemodialysis patients (discussed previously; A) andfrom all three blisters) correlated with the expression
healthy subjects (discussed later in this article; B). This shows the 10th,of CD11b on transmigrated cells (r 5 0.78, P , 0.001;
25th, 50th (median), 75th, and 90th percentiles of a variable. Please
Fig. 5). note the differences in scales in the two panels. In patients (A), P ,
0.01 control vs. active blisters; all other comparisons were not significant.
Incubation of monocytes from healthy donors in skin
blister fluid
Monocytes from healthy blood donors were incubated
of inflammation in the interstitium was equal in patientsin the three pools of skin blister fluid (time 0, control
and healthy subjects.and active chambers, altogether 50 experiments) from
patients and healthy subjects in order to determine the
Concentration of MCP-1 in serumlocal biological activity of CD11b-mobilizing factors.
The systemic concentration of MCP-1 was higher inThere were no significant differences in CD11b expres-
patients both before hemodialysis (239 6 20 ng/L) andsion on monocytes, incubated in the respective pool of
at 10 hours (202 6 14 ng/L) as compared with in healthyskin blister fluid, between patients and healthy subjects
subjects at the corresponding time points (73 6 10 and(0 h, 16.6 6 1.9 MFI vs. 15.7 6 0.7 MFI; control chamber,
50 6 7 ng/L, P , 0.001 for both comparisons). There18.2 6 1.7 MFI vs. 15.8 6 1.2 MFI; active chamber, 21.4 6
were no significant differences between values at 0 hours1.2 MFI vs. 22.2 6 1.0 MFI). In both patients and healthy
compared with 10 hours in patients or healthy controls.subjects, the CD11b expression was higher on cells incu-
The serum concentration of MCP-1 at 0 hours correlatedbated in fluid from the active chamber as compared with
with the number of transmigrating monocytes when allthe cells incubated in control chamber fluid (patients,
individuals were evaluated together (r 5 0.65, P , 0.01),P , 0.05; healthy subjects, P , 0.001). Thus, the biologi-
cal activity of CD11b-mobilizing factors at the local site but not in patients or healthy subjects separately.
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duced, representing three different states of inflamma-
tion. Cells collected by aspiration at 0 hours, 12 to 14
hours after the formation of blisters, before the adminis-
tration of either buffer or autologous serum, represent
the uremic state. It must be emphasized that no hemodi-
alysis was performed during this period as opposed to the
following blister settings. An intermediate inflammatory
reaction was induced by removal of the roof of one
of the blisters followed by instillation of buffer. The
strongest inflammatory reaction was obtained by the re-
moval of the roof of the other blister followed by the
administration of autologous serum in the chamber. Cells
in these blister fluids were recruited during 10 hours,
of which the patients underwent hemodialysis for four
hours, and thereafter collected for analysis. Similar tech-
Fig. 5. Correlation between the number of monocytes at the site of niques have been used in other groups of patients with
inflammation in the interstitium in hemodialysis patients and the expres- other objectives [13–17].
sion of CD11b/CD18 on transmigrated cells (r 5 0.78, P , 0.001).
In the present investigation, there was no significant
difference in CD11b expression on monocytes in intersti-
tial fluid aspirated from the blisters at 0 hours between
healthy subjects and patients. After 10 hours, however,DISCUSSION
monocytes in the control blister from hemodialysis pa-In this article, we show that the number of transmigrat-
tients had significantly lower cell surface expression ofing monocytes to inflammatory foci in the interstitium
CD11b as compared with cells collected in the corre-is similar in patients and healthy subjects. However,
sponding blister of healthy subjects. The reason for thismonocytes from hemodialysis patients, recruited to an
observation is not fully known, but may be a consequenceintermediate inflammatory site, had mobilized CD11b
of increased intravascular activation, due to generationto a lesser extent as compared with monocytes from
of anaphylatoxins and inflammatory cytokines, leading
healthy subjects. This was not due to a lower biological
to increased refractoriness to chemotactic factors at the
activity of chemotactic factors in skin blister fluid and in
site of inflammation in the interstitium. In an attempt
peripheral blood from patients. In fact, blister fluid from to evaluate whether a low cell surface expression of
patients contained an equal activity of CD11b-mobilizing CD11b on extravasated monocytes is a consequence of
factors as compared with healthy subjects, and serum low levels of chemotactic factors in the blister fluid,
contained a higher concentration of MCP-1. monocytes from healthy blood donors were incubated
This is the first investigation of hemodialysis patients in blister fluid collected from the active and control
in which the ability of monocytes to transmigrate and to chambers from hemodialysis patients and healthy sub-
mobilize adhesion molecules has been examined in the jects. The concentration of CD11b-mobilizing factors
interstitial fluid at the local site of inflammation. In previ- was similar in the pools of blister fluid obtained from
ous studies, these issues have been addressed and exam- patients and healthy subjects. Thus, despite the fact that
ined in a number of clinical and experimental models in monocytes from hemodialysis patients migrate into an
which different cell populations collected before, during, interstitial fluid containing equal biological activity of
and after hemodialysis have been studied [5–10]. One CD11b-mobilizing substances and the fact that the sys-
major problem in previous examinations is that it is very temic chemotactic activity in terms of MCP-1 levels are
difficult to clearly define the population of monocytes increased, they have mobilized the receptor to a signifi-
studied, since cells are sequestrated in the microcircula- cant lesser extent.
tion during the first part of dialysis and other cell popula- In the chamber containing autologous serum (intense
tions mobilized later during dialysis resulting in rebound inflammation), the cell surface expression of CD11b on
leukocytosis, which especially occurs in dialysis treat- monocytes obtained from patients increased and reached
ments using complement-activating membranes such as levels obtained in the corresponding blister fluid of
Cuprophan [5–12]. healthy individuals. Together, these observations favor
To address the question of whether the previously the view that monocytes from dialysis patients have the
described hemodialysis-induced effects on circulating capacity to mobilize CD11b to the same extent as cells
monocytes during and after hemodialysis affect their from healthy individuals at the inflammatory spot, but
ability to accumulate at the inflammatory site, we applied that a more intense stimulus is required for such actions,
probably because of a transient refractoriness. Further-a blister chamber technique. Two skin blisters were in-
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more, the number of monocytes at the site of inflamma- Several specific chemokines may be involved in the
effects observed on intravascular and extravasated mono-tion in the interstitium in patients correlated to the ex-
pression of CD11b on transmigrating cells. It must be cytes at the different levels of inflammation in the present
investigation. In a study by Kuhns, migration of leuko-emphasized that during hemodialysis, a notable variation
in blood leukocyte counts occurs because of sequestra- cytes into the skin chamber fluid was detectable within
3 hours and appeared to plateau at 16 to 24 hours [14].tion and rebound phenomenon. The impact of this on the
accumulation of monocytes rate must also be considered. Several inflammatory mediators such as interferon-g,
complement fragment C5a, leukotriene B4, IL-1, IL-6,Leukocytes play an essential role as a first-line defense
against invading microorganisms. A prerequisite for this IL-8, tumor necrosis factor, and granulocyte-macrophage
colony-stimulating factor were detected at different timeaction in inflammation is their capability to adhere to
endothelial cells, extravasate, and subsequently transmi- points [14]. Herein, we report increased levels of serum
MCP-1 in hemodialysis patients and a correlation be-grate into the surrounding interstitial tissue. Monocytes
originate from the myeloid line of differentiating cells tween MCP-1 levels and monocyte accumulation at an
inflammatory site. This implies that MCP-1, a well-char-in the bone marrow. Circulating monocytes change their
phenotype after extravasation and differentiate into tis- acterized monocyte-specific chemokine, contributes to
monocyte activation and accumulation in hemodialysissue-specific macrophages. Monocytes and macrophages
therefore are proposed to play a critical role in the initia- patients [23]. One may speculate that the higher systemic
concentration of MCP-1 in hemodialysis patients as com-tion and maintenance of inflammation and in wound
healing. Most studies on granulae content in phagocytes pared with in healthy subjects may be necessary to main-
tain monocyte recruitment and thus contribute to thehave been conducted on neutrophils, and based on these
studies, a hierarchy in mobilization of secretory vesicles, observed similar accumulation rate of monocytes at the
site of inflammation in patients and healthy subjects.gelatinase granules, specific granules, and azurophil
granules has been demonstrated [18, 19]. The granulae Other investigators have previously reported increased
levels of the neutrophil specific chemokine IL-8 in dial-characteristics in monocytes are less well known, but the
currently held concept is that monocytes contain three ysis patients [24], which supports a role for chemokines
in the recruitment of leukocytes in hemodialysis patients.populations of granules, peroxidase positive, peroxidase
The finding that inflammatory cells in patients on he-negative, and secretory vesicles, the latter containing
modialysis accumulate at an inflammatory site to theCD11b molecules [20]. Differences between monocytes
same degree as in healthy subjects but only partially up-and neutrophils with regard to the intracellular pool and
regulate their CD11b/CD18 expression may have impor-location of adhesion molecules, as well as the sensitivity
tant clinical implications. Leukocytes with cytotoxic ac-towards chemoattractants, have been reported [21].
tions have to adhere to their targets cells (for example,During the leukocyte transmigration process, a shift
virus-infected cells), mainly through CD11b/CD18 mole-in adhesion molecule phenotype generally occurs, which
cules, to kill them. CD11/CD18 also participates inincludes an up-regulation of CD11b in parallel with a
phagocytosis [reviewed in 25–27]. Thus, the reduced ca-down-regulation of l-selectin [15]. This alteration does
pacity of transmigrating monocytes collected in the inter-also occur in monocytes, even if the magnitude of the
stitium from patients on hemodialysis to mobilize CD11b/shift can be less marked than in neutrophils [22]. This
CD18 in response to intermediate inflammatory stimuliis in line with previously reported data in which we ob-
may result in a less effective host defense with regardserved a less marked hemodialysis-induced shift in adhe-
to cell adhesion and phagocytosis of microorganisms.sion molecule phenotype in circulating monocytes than
In conclusion, monocytes that extravasate and trans-in neutrophils [6–8]. By comparing neutrophils accumu-
migrate into inflammatory foci of hemodialysis patientslated in vivo in skin chambers to cells incubated under
during a 10-hour period, of which the four first hoursthe same conditions in plasma filled skin chambers,
were with Cuprophan dialysis treatment, have only par-Sengeloev et al demonstrated that granule exocytosis
tially mobilized CD11b in response to an intermediatetakes place during the transmigration and not during
inflammatory stimuli as compared with cells collectedthe stay in the collection chamber [15]. Furthermore,
from corresponding skin blisters of healthy individuals,stimulation with fMLP resulted in an additional release
despite similar local biological activity of CD11b-mobi-of granules that indicates that transmigrating leukocytes
lizing factors and increased systemic chemotactic activity.can retain their ability to respond. Our data suggest that
this ability is also valid for monocytes, which in the skin
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